Theravance Biopharma Reports Data from Phase 1b Study of TD-1473 in Oral Presentation at Digestive Disease Week (DDW) 2019; Data Demonstrate Signals of Clinical, Histologic and Biomarker Activity Suggesting Localized Target Engagement following Four Weeks

Media coverage

• Title	Theravance Biopharma Reports Data from Phase 1b Study of TD-1473 in Oral Presentation at Digestive Disease Week (DDW) 2019; Data Demonstrate Signals of Clinical, Histologic and Biomarker Activity Suggesting Localized Target Engagement following Four Weeks
  Media name/outlet	PR Newswire
  Country/Territory	United States
  Date	21/05/19
  Persons	Jean-Frédéric Colombel

• Title	Theravance Biopharma Reports Data from Phase 1b Study of TD-1473 in Oral Presentation at Digestive Disease Week (DDW) 2019
  Media name/outlet	Yahoo! Finance
  Country/Territory	United States
  Date	21/05/19
  URL	https://finance.yahoo.com/news/theravance-biopharma-reports-data-phase-110100688.html
  Persons	Jean-Frédéric Colombel

• Title	THERAVANCE BIOPHARMA : Summary ToggleTheravance Biopharma Reports Data from Phase 1b Study of TD-1473 in Oral Presentation at Digestive Disease Week (DDW) 2019
  Media name/outlet	MarketScreener.com
  Country/Territory	United States
  Date	21/05/19
  URL	https://www.marketscreener.com/news/Theravance-Biopharma-Summary-ToggleTheravance-Biopharma-Reports-Data-from-Phase-1b-Study-of-TD-147--28631606/
  Persons	Jean-Frédéric Colombel

• Title	Theravance Biopharma Reports Data from Phase 1b Study of TD-1473 in Oral Presentation at Digestive Disease Week (DDW) 2019
  Media name/outlet	Stockwatch
  Country/Territory	Canada
  Date	21/05/19
  URL	www.stockwatch.com/News/Item.aspx?bid=U-prSF57402-U%3aTBPH-20190521&symbol=TBPH&region=U
  Persons	Jean-Frédéric Colombel